USL311 is a selective inhibitor of fatty acid synthase (FASN), a key enzyme involved in lipid biosynthesis, with potential applications in oncology and neurodegenerative diseases. It has demonstrated the ability to cross the blood-brain barrier, making it a promising candidate for treating glioblastoma and other central nervous system disorders. USL311 is currently being investigated in clinical trials for its efficacy in targeting cancer metabolism and improving patient outcomes.
MedKoo Cat#: 564340
Name: USL311
CAS#: 1373268-67-7
Chemical Formula: C24H34N6O
Exact Mass: 422.2794
Molecular Weight: 422.58
Elemental Analysis: C, 68.22; H, 8.11; N, 19.89; O, 3.79
The following data is based on the product molecular weight 422.58 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
